Decreased CX3CL1 levels in the cerebrospinal fluid of patients with Alzheimer's disease

Juan R. Perea, Alberto Lleó, Daniel Alcolea, Juan Fortea, Jesús Ávila, Marta Bolós

Producció científica: Contribució a una revistaArticleRecerca

44 Cites (Scopus)

Resum

© 2018 Perea, Lleó, Alcolea, Fortea, ávila and Bolós. Alzheimer's disease (AD) is a neurodegenerative disease characterized by the presence of neurofibrillary tangles, constituted by tau protein, and plaques formed by amyloid-beta protein. The disease courses with high neural damage, which leads to memory loss and death. Here we analyzed the presence of CX3CL1, a chemokine expressed by neurons, in cerebrospinal fluid (CSF) samples from control subjects and patients with mild cognitive impairment and AD dementia. CX3CL1 was decreased in the CSF of AD dementia patients compared to control subjects. However, there was not difference in plasma samples from the same subjects.
Idioma originalEnglish
Número d’article609
RevistaFrontiers in Neuroscience
Volum12
DOIs
Estat de la publicacióPublicada - 7 de set. 2018

Fingerprint

Navegar pels temes de recerca de 'Decreased CX3CL1 levels in the cerebrospinal fluid of patients with Alzheimer's disease'. Junts formen un fingerprint únic.

Com citar-ho